Gut Microbiota in Depression: A Focus on Ketamine
According to the WHO, major depressive disorder is the leading cause of disability worldwide, and it is a major contributor to the overall global burden of disease. The pathophysiology of this common and chronic disease is still not completely understood. The gut microbiome is an increasingly recogn...
Main Authors: | Alina Wilkowska, Łukasz Piotr Szałach, Wiesław Jerzy Cubała |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Behavioral Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnbeh.2021.693362/full |
Similar Items
-
Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
by: Alina Wilkowska, et al.
Published: (2022-02-01) -
Repeated (S)-ketamine administration ameliorates the spatial working memory impairment in mice with chronic pain: role of the gut microbiota–brain axis
by: Yubin Jiang, et al.
Published: (2024-12-01) -
Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
by: Aleksander Kwaśny, et al.
Published: (2023-04-01) -
Ketamine in Bipolar Disorder: A Review
by: Wilkowska A, et al.
Published: (2020-11-01) -
Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management
by: Alina Wilkowska, et al.
Published: (2023-12-01)